selected publications
- A hybrid demultiplexing strategy that improves performance and robustness of cell hashing. Briefings in bioinformatics. 2024 Academic Article GET IT
- Lack of memory recall in human CD4 T cells elicited by the first encounter with SARS-CoV-2. iScience. 2024 Academic Article GET IT
- Epitopes recognition of SARS-CoV-2 nucleocapsid RNA binding domain by human monoclonal antibodies. iScience. 2024 Academic Article GET IT
- Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody to antigenically distinct Omicron subvariants. The Journal of clinical investigation. 2023 Academic Article GET IT
-
Cross-reactive inhibitory antibody and memory B cell responses to variant strains of Duffy binding protein II at post-Plasmodium vivax infection.
PloS one.
2022
Academic Article
GET IT
Times cited: 3 -
Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity.
Science advances.
2022
Academic Article
GET IT
Times cited: 26 -
Interferon-γ signal drives differentiation of T-bethi atypical memory B cells into plasma cells following Plasmodium vivax infection.
Scientific reports.
2022
Academic Article
GET IT
Times cited: 10 - Librator: a platform for the optimized analysis, design, and expression of mutable influenza viral antigens. Briefings in bioinformatics. 2022 Academic Article GET IT
- Broadly neutralizing antibodies target a hemagglutinin anchor epitope. Nature. 2021 Academic Article GET IT
- Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike. mBio. 2021 Academic Article GET IT
-
Improved integration of single-cell transcriptome and surface protein expression by LinQ-View.
Cell reports methods.
2021
Academic Article
GET IT
Times cited: 8 -
First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes.
Science translational medicine.
2021
Academic Article
GET IT
Times cited: 3 -
Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets.
Immunity.
2021
Academic Article
GET IT
Times cited: 74 -
Variable immunogenicity of a vivax malaria blood-stage vaccine candidate.
Vaccine.
2021
Academic Article
GET IT
Times cited: 4 -
SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the Spike.
mBio.
2021
Academic Article
GET IT
Times cited: 61 -
Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans.
Science translational medicine.
2020
Academic Article
GET IT
Times cited: 62 -
Distinct B cell subsets give rise to antigen-specific antibody responses against SARS-CoV-2.
2020
GET IT
Times cited: 1033 -
Imprinting, immunodominance, and other impediments to generating broad influenza immunity.
Immunological reviews.
2020
Information Resource
GET IT
Times cited: 8 -
The persistence of naturally acquired antibodies and memory B cells specific to rhoptry proteins of Plasmodium vivax in patients from areas of low malaria transmission.
Malaria journal.
2019
Academic Article
GET IT
Times cited: 4 -
The acquisition of long-lived memory B cell responses to merozoite surface protein-8 in individuals with Plasmodium vivax infection.
Malaria journal.
2019
Academic Article
GET IT
Times cited: 9 -
Persistence of Long-lived Memory B Cells specific to Duffy Binding Protein in individuals exposed to Plasmodium vivax.
Scientific reports.
2018
Academic Article
GET IT
Times cited: 22 -
Immunogenicity of the Plasmodium vivax merozoite surface protein 1 paralog in the induction of naturally acquired antibody and memory B cell responses.
Malaria journal.
2017
Academic Article
GET IT
Times cited: 15 -
Immunogenicity of glycosylphosphatidylinositol-anchored micronemal antigen in natural Plasmodium vivax exposure.
Malaria journal.
2017
Academic Article
GET IT
Times cited: 12 -
Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 8 in patients with P. vivax infection.
Malaria journal.
2017
Academic Article
GET IT
Times cited: 17 -
Correction: Naturally-Acquired Immune Response against Plasmodium vivax Rhoptry-Associated Membrane Antigen.
2016
GET IT
Times cited: 1 -
Naturally-Acquired Immune Response against Plasmodium vivax Rhoptry-Associated Membrane Antigen.
PloS one.
2016
Academic Article
GET IT
Times cited: 10 -
Naturally-acquired cellular immune response against Plasmodium vivax merozoite surface protein-1 paralog antigen.
Malaria journal.
2015
Academic Article
GET IT
Times cited: 13